Effects of trans-4-aminomethylcyclohexane carboxylic acid as an antifibrinolytic agent on arterial wall and experimental atherosclerotic lesions in rabbits.
D000818:Animals; D000933:Antifibrinolytic Agents / Q000494:pharmacology*; D001011:Aorta / Q000187:drug effects; D001158:Arteries / Q000187:drug effects*; D001161:Arteriosclerosis; D002199:Capillary Permeability / Q000187:drug effects; D002784:Cholesterol / Q000032:analysis; D003509:Cyclohexanecarboxylic Acids / Q000009:adverse effects / Q000494:pharmacology*; D005337:Fibrin / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis / Q000187:drug effects; D011651:Pulmonary Artery / Q000032:analysis; D011817:Rabbits; D013923:Thromboembolism
D000933:Antifibrinolytic Agents; D003509:Cyclohexanecarboxylic Acids; D005337:Fibrin; D005340:Fibrinogen; D002784:Cholesterol